Pacritinib
Pacritinib, marketed under the brand name Vonjo. it is a targeted therapy used to treat myelofibrosis, a rare bone marrow disorder. Reference standards of Pacritinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Pacritinib
[catalogue_number] => PA 16 4280000
[category_ids] => ,70,78,79,80,82,
[chemical_name] =>
[weight] => 472.59
[form] => C28H32N4O3
[cas] => 937272-79-2
[pslug] => 937272-79-2-pacritinib-pa164280000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 16 4280000
Molecular Formula : C28H32N4O3
Molecular Weight : 472.59
